Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches

References

• National Institutes of Health Consensus Development Conference Statement. Diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD). J. Am. Acad. Child Adolesc. Psychiatry39, 182–193 (2000).
   PubMed Web of Science ®Google Scholar
• Scahill L. Epidemiology of ADHD in school-age children. Child Adolesc. Psychiatry Clin. North Am.9, 541–555 (2000).
   PubMed Web of Science ®Google Scholar
• Barkley RA. Attention-deficit hyperactivity disorder. Scientific Am.8, 44–52 (1998).
   Google Scholar
• Fox AM, Mahoney WJ. Children with School Problems. Canadian Paediatric Society, Ottawa, Canada (1998).
   Google Scholar
• American Academy of Pediatrics, Committee on Quality Improvement. Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics105, 1158–1170 (2000).
   PubMed Web of Science ®Google Scholar
• Barkley RA. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment (2nd Edition). Guilford Press, NY, USA (1998).
   Google Scholar
• Goldman L, Genel M, Bezman R, Slanetz P. Diagnosis and treatment of attention deficit/hyperactivity disorder in children and adolescents. JAMA279, 1100–1107 (1998).
   PubMed Web of Science ®Google Scholar
• Mercuglioano M. What is attention-deficit/ hyperactivity disorder? Pediatric Clin. N. Am.46, 831–843 (1999).
   PubMedGoogle Scholar
• Spencer T, Biederman J, Wilens T. Attention-deficit/hyperactivity disorder and comorbidity. Pediatric Clin. N. Am.46, 915–927 (1999).
   PubMed Web of Science ®Google Scholar
• Richard W, Root II, Robert J, Resnick J. An update on the diagnosis and treatment of attention-deficit/hyperactivity disorder in children. Prof. Psychol. Res. Pr.34, 34–41 (2003).
   Google Scholar
• Owens J, Hoza B. Diagnostic utility of DSM-IV-TR symptoms in the prediction of DSM-IV-TR ADHD subtypes and ODD. J. Atten. Dis.7, 11–27 (2003).
   PubMedGoogle Scholar
• Staller J, Faraone SV. Attention-deficit hyperactivity disorder in girls: epidemiology and management. CNS Drugs20, 107–123 (2006).
   PubMed Web of Science ®Google Scholar
• Gaub M, Carlson CL. Gender differences in ADHD: a meta-analysis and critical review. J. Am. Acad. Child Adolesc. Psychiatry36, 1036–1045 (1997).
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone S, Mick E, Williamson S. Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J. Am. Acad. Child Adolesc. Psychiatry38, 966–975 (1999).
   PubMed Web of Science ®Google Scholar
• Nadeau K, Littman EB, Quinn PQ. Understanding Girls with Attention Deficit Hyperactivity Disorder. Bruner/Mazel, NY, USA (2000).
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders (4th Edition). American Psychiatric Association, Washington, USA (1994).
   Google Scholar
• Tannock R. Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research. J. Child Psychol. Psychiatry39, 65–99 (1998).
   PubMed Web of Science ®Google Scholar
• Pliszka SR, McCracken JT, Maas JW. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J. Am. Acad. Child Adolesc. Psychiatry35, 264–272 (1996).
   PubMed Web of Science ®Google Scholar
• Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am. J. Hum. Genet.63, 1767–1776 (1998).
   PubMed Web of Science ®Google Scholar
• Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J. Am. Acad. Child Adolesc. Psychiatry41, 378–385 (2002).
   PubMed Web of Science ®Google Scholar
• Linnet KM, Dalsgaard S, Obel C, Wisborg K, Henriksen TB, Rodriguez A. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am. J. Psychiatry160, 1028–1040 (2003).
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Subcommittee on Attention- Deficit/Hyperactivity Disorder and Committee on Quality Improvement. Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics108, 1033–1044 (2001).
   PubMed Web of Science ®Google Scholar
• MTA Cooperative Group. 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. Arch. Gen. Psychiatry56, 1073–1086 (1999).
   PubMed Web of Science ®Google Scholar
• Greenhill L, Pliszka S, Dulcan MK. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J. Am. Acad. Child Adolesc. Psychiatry41, S26–S49 (2002).
   PubMed Web of Science ®Google Scholar
• Angold AJ. Stimulant treatment for children: a community perspective. J. Am. Acad. Child Adolesc. Psychiatry39, 975–984 (2000).
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics, Committee on Quality Improvement. Clinical practice guidelines: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics108, 1033–1044 (2001).
   PubMed Web of Science ®Google Scholar
• Biederman J. Practical considerations in stimulant drug selection for the attention-deficit/hyperactivity disorder patient – efficacy, potency, and titration. Today’s Therapeutic Trends20, 311–328 (2002).
   Google Scholar
• Findling RL, Dogin JW. Psychopharmacology of ADHD: children and adolescents. J. Clin. Psychiatry59, 42–49 (1998).
   PubMed Web of Science ®Google Scholar
• Greenhill L, Shockey E, Halperin J, March J. Stimulants in Psychiatry (2nd Edition). Tasman A, Kay J, Lieberman JA (Eds). John Wiley & Sons, Ltd, Chichester, England, (2003).
   Google Scholar
• Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A. Non-stimulant medications in the treatment of ADHD. Eur. Child Adolesc. Psychiatry13, 102–116 (2004).
   PubMed Web of Science ®Google Scholar
• Akhondzadeh S, Tavakolian R, Davari-Ashtiani R, Arabgol F, Amini H. Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial. Prog. Neuropsychopharmacol. Biol. Psychiatry27, 841–845 (2003).
   PubMed Web of Science ®Google Scholar
• Mohammadi M, Kashani L, Akhondzadeh S, Sahimi Izadian E, Ohadinia S. Efficacy of theophylline compared to methylphenidate for the treatment of attention deficit hyperactivity disorder in children and adolescents: a double blind and randomized trial. J. Clin. Pharm. Ther.29, 139–144 (2004).
   PubMedGoogle Scholar
• MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal treatment Study of Children with ADHD. Arch. Gen. Psychiatry56, 1073–1086 (1999).
   PubMed Web of Science ®Google Scholar
• Wernicke JF, Kratochvil CJ. Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. J. Clin. Psychiatry63, 50–55 (2002).
   PubMed Web of Science ®Google Scholar
• Olvera RL, Pliszka SR, Luh J, Tatum R. An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. J. Child Adolesc. Psychopharmacol.6, 241–250 (1996).
   PubMed Web of Science ®Google Scholar
• Connor DF, Fletcher KE, Swanson JM. A meta-analysis of clonidine for symptoms of attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry38, 1551–1559 (1999).
   PubMed Web of Science ®Google Scholar
• Scahill L, Chappell PB, Kim YS. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention-deficit/hyperactivity disorder. Am. J. Psychiatry158, 1067–1074 (2001).
   PubMed Web of Science ®Google Scholar
• Conners CK, Casat CD, Gualtieri CT et al. Bupropion hydrochloride in attention deficit disorder with hyperactivity. J. Am. Acad. Child Adolesc. Psychiatry35, 1314–1321 (1996).
   PubMed Web of Science ®Google Scholar
• Swanson JM, Greenhill LL, Lopez FA et al. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J. Clin. Psychiatry67, 137–147 (2006).
   PubMed Web of Science ®Google Scholar
• Shytle RD, Silver AA, Wilkinson BJ, Sanberg PR. A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorder. World J. Biol. Psychiatry3, 150–155 (2002).
   PubMedGoogle Scholar
• Garber SW, Garber MD, Spizman RF. Beyond Ritalin. Harper Collins, NY, USA (1997).
   Google Scholar
• Gant C. Complementary medicine approaches to ADHD. Presentation to Annual Conference, American College of Advancement in Medicine (ACAM), Orlando, FL, May 1999; Laguna Hills, CA, ACAM, (1999).
   Google Scholar
• Brue AW, Oakland TD. Alternative treatments for attention deficit hyperactivity disorders: does evidence support their use. Altern. Ther. Med.8, 68–74 (2002).
   PubMed Web of Science ®Google Scholar
• Pelham WE, Murphy HA. Attention deficit and conduct disorders. In: Pharmacological and Behavioral Treatment: An Integrative Approach. Herson M (Ed.). J Wiley & Sons, NY, USA, 108–148 (1986).
   Google Scholar
• Akhondzadeh S, Mohammadi MR, Momeni F. Passiflora incarnata in treatment of attention-deficit hyperactivity disorder in children and adolescents. Therapy2, 609–614 (2005).
   Google Scholar